These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9289627)
1. [Multiple sclerosis]. Offenhäusser M; Martin R Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627 [No Abstract] [Full Text] [Related]
2. 'Time is brain' also in multiple sclerosis. Freedman MS Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740 [No Abstract] [Full Text] [Related]
3. [Multiple sclerosis: from immunopathogenesis to disease management]. Nervenarzt; 1996 Dec; 67(12 Suppl Von Der Im):1-8. PubMed ID: 9403091 [No Abstract] [Full Text] [Related]
5. [Will there soon be a sub-type specific treatment? New approaches to multiple sclerosis therapy]. MMW Fortschr Med; 2008 Apr; 150(15):17. PubMed ID: 18510111 [No Abstract] [Full Text] [Related]
6. Solving the MS puzzle. Hobson K US News World Rep; 2002 Oct; 133(13):60-2. PubMed ID: 12375480 [No Abstract] [Full Text] [Related]
7. Treatment of multiple sclerosis and other autoimmune diseases with cladribine. Beutler E; Sipe J; Romine J; McMillan R; Zyroff J; Koziol J Semin Hematol; 1996 Jan; 33(1 Suppl 1):45-52. PubMed ID: 8714617 [No Abstract] [Full Text] [Related]
8. [A short history of beta-interferon therapy of multiple sclerosis]. Stock G; Horowski R Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113 [TBL] [Abstract][Full Text] [Related]
9. Disease-modifying drugs for the early treatment of multiple sclerosis. Flachenecker P Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542 [TBL] [Abstract][Full Text] [Related]
10. [Multiple sclerosis. Biomarkers for deciding treatment]. Meinl E; Voltz R MMW Fortschr Med; 2004 May; 146 Spec No 2():57-8. PubMed ID: 15376703 [No Abstract] [Full Text] [Related]
11. Treatment of children and adolescents with multiple sclerosis. Banwell B Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672 [TBL] [Abstract][Full Text] [Related]
12. [Therapy of multiple sclerosis]. Simó M Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815 [TBL] [Abstract][Full Text] [Related]
13. [Immunosuppressive treatment of multiple sclerosis (review of the literature]. Neretin VIa; Kir'iakov VA; Sapfirova VA Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156 [No Abstract] [Full Text] [Related]
14. [Autoimmune diseases of muscle and nervous system]. Krankenpfl J; 2005; 43(7-10):236. PubMed ID: 16518891 [No Abstract] [Full Text] [Related]
15. Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much? Giacomini PS; Arnold DL; Bar-Or A; Antel JP Arch Neurol; 2009 Jan; 66(1):19-20. PubMed ID: 19139295 [No Abstract] [Full Text] [Related]
16. The use of interferon beta in relapsing-remitting multiple sclerosis. Etheridge LJ; Beverley DW; Ferrie C; McManus E Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086 [TBL] [Abstract][Full Text] [Related]
17. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis. Gout O Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028 [No Abstract] [Full Text] [Related]
18. [Pragmatic approach to treatments in multiple sclerosis]. Vermersch P Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F125-31. PubMed ID: 19593885 [No Abstract] [Full Text] [Related]
20. [Diagnostics and drug therapy of multiple sclerosis]. Suomen Neurologinen Yhdistys ry Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889 [No Abstract] [Full Text] [Related] [Next] [New Search]